3M Paid $9 Million to Make a Problem Go Away. Five Years Later It Cost $16 Billion.

In July 2018, 3M wrote a check for $9.1 million and the problem appeared to be over. The Justice Department had alleged that the company knowingly sold combat earplugs to the military without disclosing that they were too short to seat properly and could loosen imperceptibly in the ear.⁶ 3M paid, admitted nothing, and the matter resolved as allegations only.⁶ For a company its size, $9.1 million is a rounding error. It looked like the cheapest exit imaginable. Five years later, the same earplug would cost it $6 billion.⁵

The official story is that 3M faced two unrelated misfortunes — a contaminated-water crisis and a defective-product crisis — and settled both responsibly. The real story is that they are the same crisis twice, run through the same machine: tell the regulator the narrow truth, settle small and quiet when you can, and discover that a liability you didn't fully disclose doesn't shrink while it waits. It compounds.

Why a $9 million settlement became a $6 billion one

The 2018 settlement closed the government's claim. It did not close the door. Because the resolution carried no admission of liability and resolved only the federal contracting allegation, it did nothing to stop the actual users — the soldiers — from suing on their own behalf. And the internal record that surfaced along the way was damning enough to attract them. The whistleblower suit that triggered the whole sequence was filed in 2016 not by a veteran or by the government, but by Moldex-Metric Inc., a rival earplug maker, under the False Claims Act's qui tam provisions; the documents it pried loose alleged that 3M's predecessor unit, Aearo, had known about the seating defect as early as 2000.⁸ A small settlement with the Pentagon was never going to satisfy hundreds of thousands of individuals who said their hearing was the price.

Before the $6 billion deal, 3M tried the cheaper exit one more time. In July 2022 it pushed its Aearo unit into Chapter 11 bankruptcy, attaching a proposed $1 billion trust to settle the earplug claims — a move that would have frozen the litigation behind a bankruptcy shield.⁷ It is tempting to call this an attempt to 'escape liability,' but the judge's reasoning was narrower and more revealing. In June 2023, Judge Jeffrey Graham dismissed the case because Aearo wasn't actually in financial distress: it was healthy, solvent, and backed by 3M, so it had no valid reorganization purpose.⁷ The bankruptcy didn't fail because it was cynical. It failed because the unit was too healthy to need rescuing — which is exactly the tell. You cannot use a tool for the bankrupt when you are not bankrupt. Two months later, 3M settled for $6 billion in the open.⁵

The chemistry version of the same mistake

Run the PFAS story beside it and the symmetry is hard to miss. PFAS — the 'forever chemicals' that don't break down in water or bodies — were a category 3M led for decades. The clean-sounding line in most coverage is that 3M exited these chemicals long ago. It did not. In 2000, 3M announced a voluntary phaseout of two specific long-chain compounds, PFOA and PFOS, and completed most of it by 2002, the rest by 2008.⁴ That was the narrow disclosure: a public retreat from the two most notorious molecules. But the company kept manufacturing other PFAS — fluoropolymers, fluorinated fluids, additives — and only announced a full exit from all PFAS manufacturing in December 2022, to be completed by the end of 2025.³ The gap between 'we stopped' and 'we stopped two of them' is two decades of continued exposure.

The bill for the part it kept making arrived in 2023. To resolve the claims of public water suppliers — the towns and utilities that had to filter PFAS out of drinking water — 3M agreed to contribute up to a present value of $10.3 billion over 13 years.¹ Note the precise language, because the press got it wrong: the often-quoted '$10 billion settlement' is the present-value figure, while the nominal cap, if the maximum is reached, is $12.5 billion.¹ The deal won final court approval on March 29, 2024, with the first roughly $2.9 billion in payments slated to begin that summer.²⁹ Same pattern, larger zero count: disclose narrowly, settle late, pay at scale once the delay has done its compounding.

Isn't this just hindsight — and aren't all big companies sued?

The fair objection is that this is too tidy. Every industrial giant gets sued; mass torts are a structural feature of selling billions of physical things into a litigious country, not proof of a flawed strategy. And there is truth in it — a company that makes earplugs for soldiers and chemicals for half the economy will eventually be a defendant no matter how it behaves. The honest counter, though, is that the pattern isn't in being sued; it's in how 3M chose to meet the risk each time it surfaced. The 2018 settlement could have closed the user claims if it had carried disclosure and remediation; it carried neither. The 2000 PFAS retreat could have been a full exit; it was a partial one that left twenty years of exposure on the table. The Aearo bankruptcy could have been an honest restructuring; the unit wasn't distressed. At each fork, the cheaper, narrower move won — and each time, the bill didn't disappear. It waited, and grew.

Add the two reckonings and the arithmetic of delay is brutal: the $9.1 million the company once paid to make the earplug go away became part of a story that ended with a $6.0 billion earplug settlement⁵ and a PFAS settlement carrying a present value of $10.3 billion—a nominal cap of $12.5 billion if the maximum is reached.¹ 3M didn't fail because it made dangerous products; plenty of companies make hazardous things and disclose them whole. It failed because it kept choosing the narrow truth over the full one, and the narrow truth has a half-life. Every quarter it sat undisclosed, it didn't decay. It accrued. The earplug that cost $9 million in 2018 was never $9 million. It was a $6 billion liability the company hadn't finished reading yet.